New Mexico 2023 Regular Session Status: In Committee 2 D cosponsors

HB 263 — OVERDOSE PREVENTION PROGRAM

Last action — DO PASS, as amended, committee report adopted

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2023 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

290 added · 250 removed

Plain-language change summary

The recent amendment to House Bill 263 focuses on updating the Harm Reduction Act by creating an Overdose Prevention Program and establishing protections for individuals involved in harm reduction efforts. This change aims to enhance public health by reducing the risks associated with drug overdoses while ensuring that those providing assistance are shielded from legal repercussions. Such measures are crucial in addressing the ongoing crisis of substance use and could lead to better outcomes for individuals at risk.

→
Previous
Latest
HOUSE BILL 263 56TH LEGISLATURE -STATEOFNEWMEXICO- FIRST SESSION, 2023 INTRODUCED BY Tara L.
HOUSE BILL 263 56TH LEGISLATURE - STATEOFNEWMEXICO- FIRST SESSION, 2023 INTRODUCED BY Tara L.
Lujan and Dayan Hochman-Vigil 6 8 10 AN ACT RELATING TO PUBLIC HEALTH;
Lujan and Dayan Hochman-Vigil This document may incorporate amendments proposed by a committee, but not yet adopted, as well as amendments that have been adopted during the current legislative session.
AMENDING THE HARM REDUCTION ACT TO CREATE THE OVERDOSE PREVENTION PROGRAM;
The document is a tool to show amendments in context and cannot be used for the purpose of adding amendments to legislation.
LIMITING CIVIL AND CRIMINAL LIABILITY FOR PEOPLE ACTING PURSUANT TO THE HARM REDUCTION ACT.
h AN ACT g o RELATING TO PUBLIC HEALTH;
16 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
AMENDING THE HARM REDUCTION ACT TO t hr g e i k CREATE THE OVERDOSE PREVENTION PROGRAM;
e t 17 SECTION 1.
LIMITING CIVIL AND h r i s CRIMINAL LIABILITY FOR PEOPLE ACTING PURSUANT TO THE HARM h , t, REDUCTION ACT.
Section 24-2C-1 NMSA 1978 (being Laws 1997, w l n d 18 Chapter 256, Section 1) is amended to read:
e u g e b l e e h n d d i = = o h BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
= = 19 a l "24-2C-1.
l ] b ,d i a º e SECTION 1.
SHORT TITLE.--[Sections 1 through 6 of this i a e r 20 act] Chapter 24, Article 2C NMSA 1978 may be cited as the "Harm a t m m 21 Reduction Act"." d r e 22 SECTION 2.
Section 24-2C-1 NMSA 1978 (being Laws 1997, r i = r t e w d m a n o Chapter 256, Section 1) is amended to read:
Section 24-2C-3 NMSA 1978 (being Laws 1997, c e s k 23 Chapter 256, Section 3, as amended) is amended to read:
d m :
e a n b 24 "24-2C-3.
b e d s º o t n = .224044.3AIC March 9, 2023 (10:47am) s k m e e a n e d r e l u [ A d "24-2C-1.
DEFINITIONS.--As used in the Harm Reduction u [ Act:
SHORT TITLE.--[Sections 1 through 6 of this act] Chapter 24, Article 2C NMSA 1978 may be cited as the "Harm Reduction Act"." SECTION 2.
.224044.3 A.
Section 24-2C-3 NMSA 1978 (being Laws 1997, Chapter 256, Section 3, as amended) is amended to read:
"24-2C-3.
DEFINITIONS.--As used in the Harm Reduction Act:
A.
"participant" means a person who receives supplies or devices or services provided by the harm reduction program or the overdose prevention program." SECTION 3.
"participant" means a person who receives supplies or devices or services provided by the harm reduction program or the overdose prevention program ." SECTION 3.
(1) establish and administer a program that shall be known as the "harm reduction program" to reduce overdose mortality and other negative health outcomes associated with drug use;
h (1) establish and administer a program that g o t hr shall be known as the "harm reduction program" to reduce g e i k overdose mortality and other negative health outcomes h r i s associated with drug use;
(2) establish and administer a program that shall be known as the "overdose prevention program" to reduce death, disease and injury associated with drug use;
h , t, (2) establish and administer a program that e u g e b l e e h shall be known as the "overdose prevention program" to reduce n d d i = = o h death, disease and injury associated with drug use;
e t 17 [(2)] (3) pursuant to rules established by the w l n d 18 department, qualify persons as harm reduction or overdose = = 19 a l prevention program participants, issue a document that i a e r 20 identifies the bearer of the document as a participant and a t m m 21 provide the bearer of the document with access to supplies, d r e 22 devices or services provided by the program;
l ] b ,d i a º e [(2)] (3) pursuant to rules established by the r i = r t e w d m a n o department, qualify persons as harm reduction or overdose d m :
c e s k 23 [(3)] (4) compile data to assist in planning e a n b 24 and evaluating efforts to combat overdose mortality and other u [ negative health outcomes associated with drug use.
b e d s º o t n = .224044.3AIC March 9, 2023 (10:47am) s k m e - 2 - e a n e d r e l u [ A d prevention program participants, issue a document that identifies the bearer of the document as a participant and provide the bearer of the document with access to supplies, devices or services provided by the program;
The .224044.3 - 2 - department shall not collect personal data, such as the name, date of birth or address of participants;
[(3)] (4) compile data to assist in planning and evaluating efforts to combat overdose mortality and other negative health outcomes associated with drug use.
The department shall not collect HJCºpersonal data, such as the name, date of birth or address of participants»HJC HJCºthe full name or address of participants, except as required by law for testing, treatment of infectious disease or other medical treatment»HJC ;
The department shall appoint an advisory committee to include representation from:
The department shall appoint an advisory h committee to include representation from:
(1) the office of the attorney general;
g o t hr (1) the office of the attorney general;
(2) the New Mexico state police division of the department of public safety;
g e i k (2) the New Mexico state police division of h r i s the department of public safety;
(3) the infectious disease prevention and control bureau of the department;
h , t, e u g (3) the infectious disease prevention and e b l e e h control bureau of the department;
(4) the director of the epidemiology and response division of the department or the director's designee;
n d d i = = o h (4) the director of the epidemiology and l ] b ,d i a º e response division of the department or the director's designee;
(5) a medical officer of the public health division of the department;
r i = r t e w d m a n o (5) a medical officer of the public health d m :
and e t 17 (6) other persons or representatives as chosen w l n d 18 by the secretary of health to ensure a thorough and unbiased = = 19 a l evaluation of the [program] programs established under the Harm i a e r 20 Reduction Act.
b e d s º o t n = .224044.3AIC March 9, 2023 (10:47am) s k m e - 3 - e a n e d r e l u [ A d division of the department;
a t m m 21 C.
and (6) other persons or representatives as chosen by the secretary of health to ensure a thorough and unbiased evaluation of the [program ] programs established under the Harm Reduction Act.
C.
d r e 22 (1) develop policies and procedures for c e s k 23 evaluation of the harm reduction [program] and overdose e a n b 24 prevention programs;
(1) develop policies and procedures for evaluation of the harm reduction [program ] and overdose prevention programs;
u [ (2) develop criteria for data collection and .224044.3 - 3 - program evaluation;
(2) develop criteria for data collection and program evaluation;
and (3) meet as necessary to monitor and analyze data and produce a report on the [harm reduction program's] impact of the harm reduction program and the overdose prevention program on overdose mortality and other negative health outcomes associated with drug use.
and (3) meet as necessary to monitor and analyze data and produce a report on the [harm reduction program's ] impact of the harm reduction program and the overdose prevention program on overdose mortality and other negative health outcomes associated with drug use.
D.
h D.
The department may contract with private providers to operate the harm reduction program and the overdose prevention program.
The department may contract with private g o t hr providers to operate the harm reduction program and the g e i k overdose prevention program.
E.
h r i s E.
The department shall promulgate rules as necessary for the administration of the Harm Reduction Act, including developing criteria for the types of supplies or devices provided pursuant to the harm reduction [program] and overdose prevention programs and standards for distribution of those supplies or devices through [that program] those programs.
The department shall promulgate rules as h , t, necessary for the administration of the Harm Reduction Act, e u g e b l e e h including developing criteria for the types of supplies or n d d i = = o h devices provided pursuant to the harm reduction [program ] and l ] b ,d i a º e overdose prevention programs and standards for distribution of r i = r t e w d m a n o those supplies or devices through [that program ] those d m :
The criteria and standards shall be developed to e t 17 provide supplies and devices in order to reduce:
b e d s º o t n = .224044.3AIC March 9, 2023 (10:47am) s k m e - 4 - e a n e d r e l u [ A d programs.
Show all 67 changed rows (27 more)
Previous
Latest
w l n d 18 (1) cases of negative health outcomes = = 19 a l associated with drug use, such as overdoses or the spread of i a e r 20 infectious disease;
The criteria and standards shall be developed to provide supplies and devices in order to reduce:
and a t m m 21 (2) harm by promoting reduced use of non- d r e 22 sterile items and improving participant engagement in harm c e s k 23 reduction services and prevention education.
(1) cases of negative health outcomes associated with drug use, such as overdoses or the spread of infectious disease;
e a n b 24 F.
and (2) harm by promoting reduced use of non- sterile items and improving participant engagement in harm reduction services and prevention education.
When promulgating rules pursuant to the Harm u [ Reduction Act, the department shall consider the feasibility .224044.3 - 4 - of:
F.
When promulgating rules pursuant to the Harm Reduction Act, the department shall consider the feasibility of:
Section 24-2C-5 NMSA 1978 (being Laws 1997, Chapter 256, Section 5, as amended) is amended to read:
Section 24-2C-5 NMSA 1978 (being Laws 1997, h Chapter 256, Section 5, as amended) is amended to read:
"24-2C-5.
g o t hr "24-2C-5.
[PROGRAM] PROGRAMS.-- A.
[PROGRAM ] PROGRAMS.-- g e i k A.
The harm reduction program and the overdose prevention program shall provide participants with:
The harm reduction program and the overdose h r i s prevention program shall provide participants with:
[A.] (1) sterile hypodermic syringes and needles in exchange for used hypodermic syringes, needles or other objects used to inject controlled substances or controlled substance analogs into the human body;
h , t, [A.] (1) sterile hypodermic syringes and e u g e b l e e h needles in exchange for used hypodermic syringes, needles or n d d i = = o h other objects used to inject controlled substances or l ] b ,d i a º e controlled substance analogs into the human body;
[B.] (2) other objects used to prepare or consume controlled substances or controlled substance analogs;
r i = r t e w d m a n o [B.] (2) other objects used to prepare or d m :
e t 17 [C.] (3) supplies or devices used for testing w l n d 18 controlled substances or controlled substance analogs for = = 19 a l potentially dangerous adulterants;
b e d s º o t n = .224044.3AIC March 9, 2023 (10:47am) s k m e - 5 - e a n e d r e l u [ A d consume controlled substances or controlled substance analogs;
i a e r 20 [D.] (4) supplies or devices approved by the a t m m 21 department for distribution in accordance with rules d r e 22 established pursuant to Subsection E of Section 24-2C-4 NMSA c e s k 23 1978;
[C.] (3) supplies or devices used for testing controlled substances or controlled substance analogs for potentially dangerous adulterants;
e a n b 24 [E.] (5) education on the prevention of:
[D.] (4) supplies or devices approved by the department for distribution in accordance with rules established pursuant to Subsection E of Section 24-2C-4 NMSA 1978;
u [ [(1)] (a) the transmission of the human .224044.3 - 5 - immunodeficiency virus and hepatitis B and C;
[E.] (5) education on the prevention of:
[(1)] (a) the transmission of the human immunodeficiency virus and hepatitis B and C;
The overdose prevention program shall provide participants with a safe and hygienic space to administer and consume previously obtained controlled substances under the supervision of personnel trained in overdose reversal.
The overdose prevention program shall provide h participants with a safe and hygienic space to administer and g o t hr consume previously obtained controlled substances under the g e i k supervision of personnel trained in overdose reversal.
C.
h r i s C.
Controlled substances shall not be sold, purchased, traded or otherwise provided to harm reduction or overdose prevention program participants, except as otherwise allowed by law." SECTION 5.
Controlled substances shall not be sold, h , t, purchased, traded or otherwise provided to harm reduction or e u g e b l e e h overdose prevention program participants, except as otherwise n d d i = = o h allowed by law." l ] b ,d i a º e SECTION 5.
A new section of the Harm Reduction Act is enacted to read:
A new section of the Harm Reduction Act is r i = r t e w d m a n o enacted to read:
"[NEW MATERIAL] LIMITING CIVIL AND CRIMINAL LIABILITY.-- e t 17 Any person or entity, including a property owner, director, w l n d 18 manager, employee, volunteer or participant of the harm = = 19 a l reduction program or the overdose prevention program that is i a e r 20 acting pursuant to the Harm Reduction Act and in accordance a t m m 21 with all rules promulgated pursuant to that act shall not be d r e 22 subject to:
d m :
c e s k 23 A.
b e d s º o t n = .224044.3AIC March 9, 2023 (10:47am) s k m e - 6 - e a n e d r e l u [ A d "[NEW MATERIAL] LIMITING CIVIL AND CRIMINAL LIABILITY.-- Any person or entity, including a property owner, director, manager, employee, volunteer or participant of the harm reduction program or the overdose prevention program that is acting pursuant to the Harm Reduction Act and in accordance with all rules promulgated pursuant to that act shall not be subject to:
arrest, charge, prosecution or any other e a n b 24 criminal liability relating to the Controlled Substances Act u [ for any action or conduct that occurs on the site of a harm .224044.3 - 6 - reduction program or overdose prevention program;
A.
arrest, charge, prosecution or any other criminal liability relating to the Controlled Substances Act for any action or conduct that occurs on the site of a harm reduction program or overdose prevention program;
or C.
or h C.
any civil or administrative penalty or liability for conduct relating to the operation, inspection, licensing or administration of a harm reduction program or overdose prevention program unless the conduct is negligent or reckless." - 7 - 14 16 e t 17 w l n d 18 = = 19 a l i a e r 20 a t m m 21 d r e 22 c e s k 23 e a n b 24 u [ .224044.3
any civil or administrative penalty or liability u » r for conduct relating to the operation, inspection, licensing or t h g e l i administration of a harm reduction program or overdose h r i s prevention program unless the conduct is negligent or h , e h reckless." t u g e b l e e , gh - 7 - n d d i = = o h l ] b ,d i a º r e r = t e w d m a n o d m :
b r e t º o t n = .224044.3AIC March 9, 2023 (10:47am) s k m e e a n e d r e l u [ A d
View plain text versions (2)

Action History

  1. DO PASS, as amended, committee report adopted

  2. DO PASS committee report adopted

  3. Sent to House Health & Human Services Committee & House Judiciary Committee

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 0 co-sponsors · 110 not signed on

Sponsors (2)

Co-sponsors (0)

None.

Not signed on (110)

110 members have not signed on to this bill.

Show all 110 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 263?
HB 263 is sponsored by Tara L. Lujan (Democrat) and Dayan Hochman-Vigil (Democrat).
What is the current status of HB 263?
This bill died with 2023 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 263?
Track HB 263 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 263

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 263

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →